Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microfibril-associated glycoprotein 2 (MAGP-2), encoded by the MFAP2 gene, is a 25 kDa extracellular matrix protein found in microfibrils and is involved in their assembly and function[1][3]. MAGP-2 binds to fibrillin-1 and fibrillin-2, modulates extracellular matrix structure, and plays a role in regulating availability of growth factors such as TGFβ and BMPs[1][4]. Unlike MAGP-1, MAGP-2 contains an RGD integrin-binding motif, enabling interactions with αvβ3 integrins[1]. Its tissue expression is more restricted than MAGP-1. Disease associations include roles as a biomarker and contributor to cancer invasiveness, immune response regulation, and metabolic and cardiovascular disorders, primarily elucidated in animal models and correlative studies in human cancers[5][10][11]. There are no known approved drugs targeting MAGP-2 or clinical trials directly modulating its activity.
Not applicable (no drugs currently target MAGP-2; potential mechanisms discussed include modulation of TGFβ, BMP, and Notch signaling based on its biological interactions)[1][4]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microfibril-associated glycoprotein 2 (MAGP-2).